Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001221508-14-000007
Filing Date
2014-05-06
Accepted
2014-05-06 13:43:03
Documents
10
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 MLPH FORM 10Q 03-31-2014 form10q_03312014.htm 10-Q 427011
2 MLPH FORM EX 31 03-31-2014 ex311_03312014.htm EX-31 4670
3 MLPH FORM EX 31 03-31-2014 ex312_03312014.htm EX-31 4637
4 MLPH FORM EX 32 03-31-2014 ex32_03312014.htm EX-32 3033
  Complete submission text file 0001221508-14-000007.txt   1855618

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE - 03-31-2014 mlph-20140331.xml EX-101.INS 269575
6 XBRL SCHEMA FILE - 03-31-2014 mlph-20140331.xsd EX-101.SCH 11525
7 XBRL CALCULATION FILE - 03-31-2014 mlph-20140331_cal.xml EX-101.CAL 15064
8 XBRL DEFINITION FILE - 03-31-2014 mlph-20140331_def.xml EX-101.DEF 16289
9 XBRL LABEL FILE - 03-31-2014 mlph-20140331_lab.xml EX-101.LAB 95745
10 XBRL PRESENTATION FILE - 03-31-2014 mlph-20140331_pre.xml EX-101.PRE 63478
Mailing Address SUITE 1023 8721 SANTA MONICA BOULEVARD LOS ANGELES CA 900694507
Business Address DRUG DISCOVERY RESEARCH CENTRE 284 OXFORD STREET, LEEDERVILLE 6007 PERTH, WESTERN AUSTRALIA C3 00000 011-61-8-9443-3011
Molecular Pharmacology (USA) Ltd. (Filer) CIK: 0001191357 (see all company filings)

EIN.: 710900799 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-50156 | Film No.: 14816359
SIC: 2834 Pharmaceutical Preparations